Ameresco (AMRC) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
4 Aug, 2026Executive summary
Achieved record $1.8B in new project awards, primarily driven by data center power infrastructure projects, and closed the Neogenyx JV with HASI, securing $400M in external capital.
Q2 2026 revenue grew 9% year-over-year to $515.5M, with broad-based growth across all core business lines and strong gains in U.S. Federal, Europe, and Renewable Fuels segments.
Net income attributable to common shareholders was $9.7M ($0.18 per diluted share), with Non-GAAP EPS of $0.20, impacted by higher non-controlling interest allocations.
Adjusted EBITDA rose 12% to $62.8M, with Assets contributing 55% and O&M 16%.
Total backlog increased 32% year-over-year to $6.73B, providing strong multi-year revenue visibility.
Financial highlights
Q2 2026 gross profit increased 24.5% year-over-year to $91.3M, with gross margin rising to 17.7%.
Project revenue was $380.9M (up 6%), Energy Asset revenue $75.9M (up 21%), and O&M revenue $36.2M (up 29%).
Adjusted EBITDA margin reached 12.2% for the quarter.
Cash and cash equivalents at June 30, 2026 were $138.3M; total corporate debt at $384.8M.
Net debt at June 30, 2026: $1.79B (long-term portion).
Outlook and guidance
Reaffirmed full-year 2026 guidance across all metrics, with increased Non-GAAP EPS guidance to $1.15–$1.35.
FY 2026 revenue guidance range: $2.0–$2.2B; gross margin 17–18%; adjusted EBITDA $250–$270M.
Effective tax rate expected between 25%–40% due to new accounting policy for transferable tax credits.
Second half expected to follow normal seasonal cadence, with activity weighted toward Q4.
Capital expenditures for the remainder of 2026 projected at $120M–$170M, with $50M–$75M for the Neogenyx JV.
Latest events from Ameresco
- Strong growth, diversified backlog, and sustainability focus drive robust financial outlook.AMRC
Investor presentation3 Aug 2026 - Q3 2024 revenue up 49%, record Adjusted EBITDA, and strong backlog support growth outlook.AMRC
Q3 20248 Jul 2026 - Strong recurring earnings, major biofuels JV, and robust growth in energy solutions and sustainability.AMRC
Investor presentation24 Jun 2026 - All proposals, including director elections and plan amendments, were approved unanimously.AMRC
AGM 20264 Jun 2026 - Revenue up 14% to $401.5M; $400M HASI JV announced; net loss $18.3M; $5.3B backlog.AMRC
Q1 20265 May 2026 - Record 2025 results and 2026 guidance show strong growth, backlog, and margin expansion.AMRC
Q4 20255 May 2026 - Annual meeting to vote on directors, auditor, stock plan increase, and executive pay.AMRC
Proxy filing23 Apr 2026 - Annual meeting covers director elections, auditor ratification, equity plan amendment, and say-on-pay.AMRC
Proxy filing23 Apr 2026 - Strong earnings growth, robust backlog, and major CO₂ reductions drive sustainable value.AMRC
Investor presentation16 Mar 2026